BCRX
Price
$9.91
Change
-$0.19 (-1.88%)
Updated
Jun 23, 04:59 PM (EDT)
Capitalization
2.11B
37 days until earnings call
VKTX
Price
$24.90
Change
-$1.11 (-4.27%)
Updated
Jun 23, 04:59 PM (EDT)
Capitalization
2.79B
29 days until earnings call
Interact to see
Advertisement

BCRX vs VKTX

Header iconBCRX vs VKTX Comparison
Open Charts BCRX vs VKTXBanner chart's image
BioCryst Pharmaceuticals
Price$9.91
Change-$0.19 (-1.88%)
Volume$48.33K
Capitalization2.11B
Viking Therapeutics
Price$24.90
Change-$1.11 (-4.27%)
Volume$67.4K
Capitalization2.79B
BCRX vs VKTX Comparison Chart in %
Loading...
BCRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BCRX vs. VKTX commentary
Jun 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCRX is a Buy and VKTX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 24, 2025
Stock price -- (BCRX: $9.91 vs. VKTX: $24.86)
Brand notoriety: BCRX: Notable vs. VKTX: Not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCRX: 52% vs. VKTX: 199%
Market capitalization -- BCRX: $2.11B vs. VKTX: $2.79B
BCRX [@Biotechnology] is valued at $2.11B. VKTX’s [@Biotechnology] market capitalization is $2.79B. The market cap for tickers in the [@Biotechnology] industry ranges from $326.23B to $0. The average market capitalization across the [@Biotechnology] industry is $2.36B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCRX’s FA Score shows that 1 FA rating(s) are green whileVKTX’s FA Score has 0 green FA rating(s).

  • BCRX’s FA Score: 1 green, 4 red.
  • VKTX’s FA Score: 0 green, 5 red.
According to our system of comparison, BCRX is a better buy in the long-term than VKTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCRX’s TA Score shows that 4 TA indicator(s) are bullish while VKTX’s TA Score has 2 bullish TA indicator(s).

  • BCRX’s TA Score: 4 bullish, 4 bearish.
  • VKTX’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, BCRX is a better buy in the short-term than VKTX.

Price Growth

BCRX (@Biotechnology) experienced а -3.69% price change this week, while VKTX (@Biotechnology) price change was -7.79% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.24%. For the same industry, the average monthly price growth was +27.91%, and the average quarterly price growth was +12.28%.

Reported Earning Dates

BCRX is expected to report earnings on Jul 31, 2025.

VKTX is expected to report earnings on Jul 23, 2025.

Industries' Descriptions

@Biotechnology (-2.24% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VKTX($2.79B) has a higher market cap than BCRX($2.11B). BCRX YTD gains are higher at: 31.782 vs. VKTX (-38.221). BCRX has higher annual earnings (EBITDA): 47.6M vs. VKTX (-171.93M). VKTX has more cash in the bank: 852M vs. BCRX (295M). VKTX has less debt than BCRX: VKTX (1M) vs BCRX (795M). BCRX has higher revenues than VKTX: BCRX (503M) vs VKTX (0).
BCRXVKTXBCRX / VKTX
Capitalization2.11B2.79B76%
EBITDA47.6M-171.93M-28%
Gain YTD31.782-38.221-83%
P/E RatioN/AN/A-
Revenue503M0-
Total Cash295M852M35%
Total Debt795M1M79,500%
FUNDAMENTALS RATINGS
BCRX vs VKTX: Fundamental Ratings
BCRX
VKTX
OUTLOOK RATING
1..100
5957
VALUATION
overvalued / fair valued / undervalued
1..100
33
Fair valued
39
Fair valued
PROFIT vs RISK RATING
1..100
7278
SMR RATING
1..100
10091
PRICE GROWTH RATING
1..100
4086
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BCRX's Valuation (33) in the Biotechnology industry is in the same range as VKTX (39). This means that BCRX’s stock grew similarly to VKTX’s over the last 12 months.

BCRX's Profit vs Risk Rating (72) in the Biotechnology industry is in the same range as VKTX (78). This means that BCRX’s stock grew similarly to VKTX’s over the last 12 months.

VKTX's SMR Rating (91) in the Biotechnology industry is in the same range as BCRX (100). This means that VKTX’s stock grew similarly to BCRX’s over the last 12 months.

BCRX's Price Growth Rating (40) in the Biotechnology industry is somewhat better than the same rating for VKTX (86). This means that BCRX’s stock grew somewhat faster than VKTX’s over the last 12 months.

BCRX's P/E Growth Rating (100) in the Biotechnology industry is in the same range as VKTX (100). This means that BCRX’s stock grew similarly to VKTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BCRXVKTX
RSI
ODDS (%)
Bearish Trend 1 day ago
77%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
77%
Momentum
ODDS (%)
Bearish Trend 1 day ago
77%
Bearish Trend 1 day ago
88%
MACD
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
82%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
80%
Bearish Trend 1 day ago
86%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
87%
Advances
ODDS (%)
Bullish Trend 15 days ago
79%
Bullish Trend 18 days ago
81%
Declines
ODDS (%)
Bearish Trend 6 days ago
80%
Bearish Trend 1 day ago
85%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
87%
Bearish Trend 1 day ago
83%
Aroon
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
BCRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FMGIX16.350.17
+1.05%
Frontier MFG Core Infrastructure Instl
JLGMX84.65N/A
N/A
JPMorgan Large Cap Growth R6
LMCSX32.39N/A
N/A
Lord Abbett Mid Cap Stock R4
STRSX27.34N/A
N/A
Sterling Capital Special Opps R6
GQRIX18.63N/A
N/A
GQG Partners Global Quality Equity Instl

BCRX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, BCRX has been loosely correlated with VCYT. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if BCRX jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCRX
1D Price
Change %
BCRX100%
-1.88%
VCYT - BCRX
46%
Loosely correlated
+1.21%
CRNX - BCRX
40%
Loosely correlated
-0.83%
HOWL - BCRX
40%
Loosely correlated
+5.04%
VKTX - BCRX
39%
Loosely correlated
-4.42%
CLDX - BCRX
39%
Loosely correlated
-0.54%
More

VKTX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, VKTX has been loosely correlated with GPCR. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if VKTX jumps, then GPCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VKTX
1D Price
Change %
VKTX100%
-4.42%
GPCR - VKTX
51%
Loosely correlated
+1.70%
CRNX - VKTX
48%
Loosely correlated
-0.83%
KRYS - VKTX
47%
Loosely correlated
+4.12%
ALT - VKTX
47%
Loosely correlated
-0.57%
ROIV - VKTX
45%
Loosely correlated
+0.48%
More